![](/img/cover-not-exists.png)
The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri ® PharmacoEconomics (TyPE) Study
Polistena, B, Spandonaro, F, Capra, R, Fantaccini, S, Santoni, L, Zimatore, GB, Gasperini, CVolume:
2019
Language:
english
Journal:
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
DOI:
10.1177/2284240319852956
Date:
January, 2019
File:
PDF, 327 KB
english, 2019